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Hepatitis E virus (HEV) genotype 3, which usually 
causes asymptomatic infection in Japan, induced severe 
hepatitis in 8 patients. To better understand genetic features 
of HEV associated with increased virulence, we determined 
the complete or near-complete nucleotide sequences of 
HEV from these 8 patients and from 5 swine infected with 
genotype 3 strain swJ19. Phylogenetic analysis showed that 
the isolates from the 8 patients and the 5 swine grouped 
separately from the other genotype 3 isolates to create a 
unique cluster, designated JIO. The human JIO-related vi-
ruses encoded 18 amino acids different from those of the 
other HEV genotype 3 strains. One substitution common to 
almost all human HEV strains in the JIO cluster was located 
in the helicase domain (V239A) and may be associated with 
increased virulence. A zoonotic origin of JIO-related viruses 
is suspected because the isolates from the 5 swine also 
possessed the signature V239A substitution in helicase.
H
epatitis E virus (HEV) infection is relatively com-
mon. Anti-HEV antibodies are found in 10%–20% 
of the general population in Japan and most Asian coun-
tries (1,2); however, only a small fraction of these infec-
tions induce overt hepatitis. Although the mechanisms 
underlying induction of liver damage by HEV have not 
been well characterized, HEV genotypes seem to have 
distinct disease-inducing potential. HEV sequences have 
been classiﬁ  ed into 4 genotypes (3). Genotype 1 consists 
of epidemic strains in developing countries of Asia and 
Africa. Genotype 2 is represented by the prototype se-
quences from an epidemic in Mexico, which have also 
recently been detected in Africa. Genotypes 3 and 4 are 
distributed worldwide and have been implicated in spo-
radic cases of acute hepatitis E in humans and domestic 
pigs. HEV genotypes 3 and 4 are found in Japan, but ful-
minant or severe acute hepatitis develops more frequently 
in persons infected with genotype 4 (4–6). The severity 
of liver disease may therefore be inﬂ  uenced by the HEV 
genotype with which the patient is infected as well as host 
factors such as age, gender, and pregnancy status.
In 1997, we identiﬁ  ed a strain of HEV from a pa-
tient in Japan who had acute hepatitis (designated JIO) 
that clustered with genotype 3 sequences. From 2004 
through 2006, JIO-related viruses were isolated from 
7 additional patients who had acute or severe hepatitis. 
To better understand genetic features of HEV associated 
with severe hepatitis, we compared the complete or near-
complete sequence of JIO isolates from these 8 patients 
with other well-characterized genotype 3 and 4 isolates. 
To determine whether these human genotype 3 sequences 
were zoonotic in origin, we sequenced full-length viral 
genomes from 5 swine infected with the swJ19 strain of 
HEV. These 5 animals were part of a larger outbreak of 
HEV infection that occurred in swine at a single farm in 
southern Japan during 2000–2002. The GenBank/EMBL/
DDBJ accession numbers for nucleotide sequences of 
HEV isolates are AB291951–7/AB291960 (for the human 
isolates) and AB443623-7 (for the swine isolates).
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Methods
We enrolled 8 patients who were infected with HEV 
genotype 3 and had clinical features of hepatitis (Table 1). 
A zoonotic source of HEV infection was identiﬁ  ed for 3 of 
these patients: pig liver for patient 4, pig meat for patient 6, 
and wild boar meat for patient 7. Prothrombin time, a sur-
rogate marker of hepatic insufﬁ  ciency, averaged 63.9% (± 
29.1%) of the reference range among the 8 HEV genotype 
3–infected patients. Hepatitis was particularly severe in pa-
tients 3, 5, 7, and 8; at the peak of disease, prothrombin 
times for these patients ranged from 27% to 46% of the 
reference range. These sporadic HEV cases were not clus-
tered geographically; they were distributed across several 
regions of Japan, including southern (Okinawa) and north-
ern (Saitama) prefectures (Figure 1). Informed consent was 
obtained from all patients after the nature and purpose of 
the study was explained to them.
To assess possible zoonotic origins of these human 
infections, we sequenced HEV strain swJ19 isolates from 
5 of 11 swine with previously documented infections (7). 
These animals had been raised commercially at a farm in 
the southern part of Miyazaki Prefecture where HEV in-
fections were detected during 2000–2002. All animals re-
ceived humane care, and the study was approved by the in-
stitutional review committee of Toshiba General Hospital, 
Tokyo, Japan.
To determine whether infections could be linked to a 
common genotype 3 virus, we compared the genetic struc-
ture and sequence homology of 8 human and 5 swine HEV 
strains. The entire or near-complete nucleotide sequences 
of the 8 JIO strain isolates from the human patients and 
the swJ19 strain isolates from the 5 swine were deter-
mined by a method reported previously (8,9), with some 
modiﬁ  cations. In brief, nucleic acids were extracted from 
serum with the QIAamp MinElute Virus Spin Kit (QIA-
GEN GmbH, Hilden, Germany). HEV RNA genomes were 
reverse transcribed, and cDNA was ampliﬁ  ed by PCR with 
primers speciﬁ  c for 23 overlapping regions of the HEV 
genome. Reverse transcription and ﬁ  rst-round PCR were 
conducted by using the SuperScript III One-Step RT-PCR 
System (Invitrogen Corporation, Carlsbad, CA, USA); sec-
ond-round PCR was conducted with the Platinum Taq DNA 
polymerase (Invitrogen). The 5′- and 3′-terminal sequences 
were ampliﬁ  ed by using the SMART RACE cDNA Ampli-
ﬁ  cation Kit (Clontech Laboratories Inc., Mountain View, 
CA, USA) and Oligo (dt)20 Primer (Invitrogen), respec-
tively. The sequences enriched in G-C were ampliﬁ  ed with 
the TaKaRa LA Taq in GC Buffer (TaKaRa Shuzo Co. 
Ltd., Shiga, Japan). The sequences not ampliﬁ  able by the 
above PCR methods were subjected to PCR with primers 
deduced from adjacent 5′ and 3′ sequences. The ﬁ  nal prod-
ucts were sequenced in the 377 DNA Sequencer with use 
of the BigDye Terminator v1.1 Cycle Sequencing Kit (Ap-
plied Biosystems, Foster City, CA, USA). Genetic analyses 
of HEV sequences were conducted by the unweighted pair-
grouping method with arithmetic means by using computer 
software GENTYX-MAC Version 13 (Genetyx Corpora-
tion, Tokyo, Japan).
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Table 1.  Profiles of 8 patients infected with hepatitis E virus, JIO strain, Japan* 
Patient
no. Age, y/sex  Residence
Month of 
disease onset Diagnosis
Nadir PT, 
%
Presumed route of 
transmission Isolate name 
1 50/M Saitama 1997 Apr  Acute hepatitis  100 Unknown  JIO-Sai97L
2 76/M Tottori 2004 Jan Acute hepatitis  92 Unknown  JYM-Tot04L 
3 63/M Okinawa  2004 May  Acute hepatitis  46 Unknown  JYU-Oki04L 
4 71/F Okayama  2004 Dec  Acute hepatitis 75 Pig liver  JSS-Oka04L
5 65/M Tottori 2005 Jun Acute severe hepatitis  34 Unknown  JIY-Tot05L 
6 78/M Okinawa  2005 Jul  Acute hepatitis  92 Pig meat  JSO-Oki05L
7 63/M Kagawa  2006 Mar Acute hepatitis  45† Wild boar meat  JTK-Kag06C
8 79/M Kyoto  2006 Sep Fulminant hepatitis  27 Unknown  JSW-Kyo-FH06L 
*PT, prothrombin time. 
†Only 1 determination was made. 
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Figure 1. Map of Japan showing prefectures where human cases 
of hepatitis E virus have been found. Underlining indicates part of 
prefecture name included in isolate name; yellow indicates cases in 
swine; red indicates cases in humans.RESEARCH
Results
The prototypical isolate, JIO-Sai97L, had a genome 
length of 7,215 nt that contained a 5′ untranslated region 
(UTR), 3 open reading frames (ORFs), a 3′ UTR, and a 
poly-A tail. Lengths of HEV genomes from 6 other patients 
(JYM-Tot04L, JYU-Oki04L, JSS-Oka04L, JIY-Tot05L, 
JSO-Oki05L and JSW-Kyo-FH05L) were identical to that 
of JIO-Sai97L. An exception was the HEV isolate JTK-
Kag06C from patient 7, which was slightly longer (7,236 nt). 
The 5 HEV isolates from swine (swJ19-1, swJ19-2, swJ19-5, 
swJ19-7, and swJ19-8) had genomes of 7,210 nt. The 3 ORFs 
of all swine and human HEV genomes had identical protein 
coding capacity. HEV isolates from all human patients had 
97.9%–98.6% sequence homology with the prototypical 
JIO-Sai97L strain from patient 1. The 5 swine swJ19 isolates 
had 98.3%–99.9% sequence homology when compared with 
each other and 98.0%–99.8% homology when compared 
with the JIO strain from human patients.
Comparison of nucleotide sequences of the 13 human 
and swine HEV isolates in this study with those of pub-
lished HEV genotype 3 sequences showed that the 13 com-
plete and near-complete sequences described in this study 
closely matched those of 2 well-characterized genotype 
3 viruses: JRA1 (89.4%–89.7% nucleotide identity) and 
swJ570 (88.9%–89.0% nucleotide identity). The 13 human 
and swine genotype 3 isolates displayed weak homology 
with other HEV genotypes. The B1 isolate of genotype 1 
(GenBank accession no. M73218) was only 74.1%–74.7% 
similar to these genotype 3 viruses, the M1 isolate of gen-
otype 2 (accession no. M74506) was only 73.6%–74.0% 
similar, and the T1 isolate of genotype 4 (accession no. 
AJ272108) was only 75.6%–76.0% similar.
Using the 13 complete or near-complete genomic se-
quences of HEV genotype 3 isolates described in this study 
(Figure 2), we constructed a phylogenetic tree. HEV se-
quences from the 8 patients (JTK-Kag06C, JYU-Oki04L, 
JSS-Oka04L, JIO-Sai97L, JSO-Oki05L, JSW-Kyo-FH06L, 
JIY-Tot05L, JYM-Tot04L) clustered on a branch separate 
from the other genotype 3 sequences, forming a distinct 
grouping related to the prototypical JIO strain. The swJ19 
HEV sequences from the 5 swine (swJ19-1, swJ19-2, 
swJ19-7, swJ19-5, and swJ19-8) clustered closely with 
the JIO-related viruses from the human patients, indicating 
that the human and swine HEV isolates were highly simi-
lar (Figure 2, panel A). Another 18 swine isolates, from 
farms other than the 1 involved in the swJ19 outbreak, were 
phylogenetically distinct from those of the outbreak farms 
(Figure 2, panel B).
Another genotype 3 cluster was formed by 6 isolates 
from Hyogo Prefecture in western Japan (Figure 2, panel 
A). In this cluster were 5 HEV isolates from persons in 
whom hepatitis developed after they ate uncooked deer 
meat (10) and from serum from a local boar and a deer 
(11). Unlike the JIO-related viruses, which were broadly 
distributed from the most southern to northern Japanese 
prefectures, HEV strains responsible for the infections in 
Hyogo Prefecture were not commonly found in other parts 
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Figure 2. A) Phylogenetic tree (unweighted pair-grouping method 
with arithmetic means) constructed on the complete or near-
complete nucleotide sequences of hepatitis E virus (HEV) genotype 
3 isolates. Clustering of nucleotide sequences of 8 human patients 
infected with JIO strain of HEV and 5 swine infected with swJ19 
strain of HEV is boxed by a solid line. Another clustering of local 
genotype 3 isolates from Hyogo Prefecture, Japan, is boxed by a 
dotted line. B) Phylogenetic tree (unweighted pair-grouping method 
with arithmetic means) constructed on a partial sequence of 412 nt 
in open reading frame (ORF) 2 (nt 5994-6405 of the US2 genome) 
of HEV genotype 3. Partial nucleotide sequences of 8 human JIO 
and 11 swine HEV swJI9 isolates (accession nos. AB094279–
AB094289) are shown (shading). Analyses of full sequences of 
5 of these 11 swine isolates were performed (swJ19-1, swJ19-2, 
swJ19-5, swJ19-7, and swJ19-8). Scale bars indicate nucleotide 
substitutions per site; boldface indicates isolates from humans. Virulent Strain of Hepatitis E Virus Genotype 3
of the country. Broad distribution of the JIO-related viruses 
seems to be unique in HEV epidemiology. In 2 (25%) of 
these 8 patients, pig liver or meat had been implicated in 
HEV infection.
Comparison of the 13 JIO-related viruses (Figure 2, 
panel A) with the other genotype 3 strains also showed 18 
aa differences: 12 in ORF1, 3 in ORF2, and 3 in ORF3 
(Table 2). Three mutations in the JIO strain were character-
istic of genotype 4 viruses, which are typically more patho-
genic than other HEV genotypes. ORF1 differences were 
found at amino acids 605 (serine to proline, S605P), 978 
(isoleucine to valine, I978V), and 1213 (valine to alanine, 
V1213A). The V1213A substitution is potentially most rel-
evant because it was not found in the prototypical isolate 
from patient 1 (JIO), who had mild clinical disease when 
infected in 1997, but was present in highly related isolates 
from the other 7 patients who had more severe hepatitis dur-
ing 2004–2006. V1213A in ORF1 corresponds to V239A 
of the helicase domain, and its surrounding sequences were 
well conserved in HEV isolates of genotypes 3 and 4 (on-
line Appendix Figure, available from www.cdc.gov/EID/
content/15/5/704-appF.htm). Because V239A is common 
in genotype 4 isolates, we analyzed genomes of the geno-
type 3 JIO-related viruses for evidence of intergenotypic 
recombination. Comparison of 28 genotype 4 sequences 
with those of the JIO-related isolates showed no obvious 
signs of recombination (data not shown), which suggests 
that the V293A substitution arose independently in this ge-
netically unique cluster of genotype 3 viruses. Notably, all 
5 isolates recovered from swine on the Miyazaki Prefec-
ture farm during the outbreak of 2000–2002 possessed the 
V239A substitution.
Discussion
Circumstantial evidence indicates that HEV geno-
type inﬂ  uences the severity of liver disease. Remarkably, 
HEV seroprevalence studies in Egypt found no clinical ill-
ness in any person, including pregnant women, although 
most (67.7%–84.3%) had been exposed to HEV genotype 
3 (13,14). In contrast, results of a survey of 254 patients 
with HEV infection in Japan showed hepatitis associated 
with genotype 4 to be more severe than that associated with 
genotype 3 (4). Our results showed a clustering of 8 HEV 
isolates of JIO strain, genotype 3, recovered from patients 
with clinical hepatitis.
Despite the high disease-inducing activity of the HEV 
JIO strain, the 8 patients infected with this strain were 
distributed widely over Japan. This distribution is at odds 
with a local cluster of genotype 3 infections restricted to 
persons with hepatitis and to wild animals living in Hyogo 
Prefecture, Japan (Figure 2, panel A) (11). Wide regional 
distribution has also been reported for some HEV geno-
type 4 isolates (15). Why JIO strains caused more severe 
hepatitis than might be expected for a genotype 3 virus is 
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Table 2. Amino acid residues in 8 human and 5 swine hepatitis E virus isolates compared with those in the other genotype 3 isolates*
Human no.  Swine no.  Amino acid 
position†
Conserved in 
genotype 3  1    2345678 12345
Conserved in 
genotype 4 
ORF1 
  154  A A   T A A T T A T A   A T A T T
  547  R Q   Q Q Q Q Q Q Q Q   Q Q Q Q R
 598  R Q    QQQQQQQ Q    QQQQ K
 605 S P    PPPPPPP P    PPPP P
  721  A T   T T T T T T T T   T T T T A
 807  A S S S S S S S S S    S S S S A
 978 I V    VVVVVVV V    VVVV V
  979  S K   K K K K K K K K   K K K K E
 1135  I T    T T T TTTT T    TTTT V
 1213‡ V V    AAAAAAA A    AAAA A
 1246  Q H    HHHHHHH H    HHHH D
  1469  C S   S S S S S S S S   S S S S C
ORF2 
  9 8   P S    SPPSSPP P    PSPS A
 113  V/I T T T T T T T T T T T T T V
  660  S S   S S F F F S F S   S S S S Y 
ORF3 
  9 1   S N    NNNNNNN N    NNNN S
  9 7   A A    VVVVVVV V    VVVV A
  9 8   P   Q    QQQQQQQ Q    QQQQ P  
*Eighteen amino acids of 8 human isolates (JIO strain) and 5 swine isolates (swJ19 strain) not shared by other genotype 3 isolates. The 3 at positions 
605, 978, and 1213 (boldface) were the same as the corresponding residues in genotype 4 isolates. 
†Corresponds to the position in hepatitis E virus (HEV)-US2 (GenBank/EMBL/DDBJ accession no, AF060669) (12). 
‡V1213A in the open reading frame (ORF) 1 polyprotein corresponds to V239A in the HEV-US2 genotype 3 isolate helicase domain within ORF1 (online 
Appendix Figure, available from www.cdc.gov/EID/content/15/5/704-appF.htm). RESEARCH
not clear, but the reason may depend on the magnitude of 
virus replication. Alternatively, recombination between di-
vergent HEV strains (16) may have played a role. This pos-
sibility prompted us to look for any recombination of JIO 
strains with genotype 4 strains that cause severe hepatitis 
in Japan. However, we found no evidence of recombina-
tion between the JIO strain of genotype 3 HEV with which 
the 8 persons were infected and 28 isolates of genotype 4 
retrieved from the public and our own databases. The 18 aa 
substitutions were unique to the 8 human JIO and 5 swine 
sw19 isolates and not present in other genotype 3 viruses. 
Three differences in ORF1 (S605P, I978V, and V1213A) 
were common in wild type genotype 4 but not in genotype 
3 isolates (Table 2). Because S605P and I978V are located 
in an ORF1 region that has high sequence divergence, they 
are unlikely to be responsible for an enhanced disease-
inducing capacity. In contrast, V1213A changes at amino 
acid 239 of helicase, an enzyme capable of enhancing the 
efﬁ  ciency of viral replication (17), were detected in 7 of the 
8 patients (online Appendix Figure). Indeed, the helicase 
region of the prototypical JIO-Sai97L isolated in 1997 did 
not contain this amino acid polymorphism. Remarkably, 
all 5 swine isolates recovered in Miyazaki Prefecture dur-
ing 2000–2002 belonged to the JIO strain and possessed 
V1213A (helV239A). Taken together, the evidence strong-
ly suggests a zoonotic origin for the 8 human HEV infec-
tions with JIO-related viruses.
Experimental and circumstantial evidence suggests 
that helV239A may have enhanced the helicase activity of 
the genotype 3 JIO strain to levels comparable with those 
of the more pathogenic genotype 4 viruses. However, the 
role of helV239A in enhancing helicase activity should be 
evaluated in vitro in future studies; its role in inducing hep-
atitis is yet to be conﬁ  rmed. In addition, the effect of other 
mutations of JIO strains need to be fully explored before a 
conclusion can be drawn regarding the hepatitis-inducing 
capacities of this strain of HEV.
Findings from this study have public health implica-
tions. Because farm swine constitute a melting pot for gen-
erating various HEV mutants, at least in Japan where virtu-
ally all swine become infected with HEV within 4 months 
of birth, it is conceivable that virulent HEV mutant(s) arise 
on pig farms. Such occurrence has been described for in-
ﬂ  uenza, for which point mutations are associated with in-
creased virulence (18,19); for example, mutant inﬂ  uenza 
viruses that arose on chicken farms in Hong Kong in 1997 
were transmitted to humans and had fatal consequences 
(20,21). In addition, although a vaccine against HEV has 
recently been developed (22), a vaccination strategy for 
humans and animals has yet to be deﬁ  ned. The results of 
our study indicate that selective vaccination of farm swine 
bearing HEV isolates of high virulence, such as those of the 
JIO strain in Miyazaki Prefecture, should be recommended 
to decrease the incidence of fulminant or severe acute hepa-
titis E in Japan and elsewhere in the world.
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